<?xml version="1.0" encoding="UTF-8"?>
<rss  xmlns:atom="http://www.w3.org/2005/Atom" 
      xmlns:media="http://search.yahoo.com/mrss/" 
      xmlns:content="http://purl.org/rss/1.0/modules/content/" 
      xmlns:dc="http://purl.org/dc/elements/1.1/" 
      version="2.0">
<channel>
<title>HUAT-RRR</title>
<link>https://.com/ebp.html</link>
<atom:link href="https://.com/ebp.xml" rel="self" type="application/rss+xml"/>
<description>RRR Resources</description>
<generator>quarto-1.2.262</generator>
<lastBuildDate>Wed, 15 Jul 2020 16:00:00 GMT</lastBuildDate>
<item>
  <title>Regression</title>
  <dc:creator>SGH PT Dept</dc:creator>
  <link>https://.com/ebp/regression/regression.html</link>
  <description><![CDATA[ <section id="definitions" class="level2 page-columns page-full"><h2 class="anchored" data-anchor-id="definitions">Definitions</h2>
<p><strong>linear regression model</strong>: This is also called ordinary least squares (OLS) and refers to regression for a continuous dependent variable, and usually to the case where the residuals are assumed to be Gaussian.</p>
<p><strong>multivariable model</strong>: A model relating multiple predictor variables (risk factors, treatments, etc.) to a single response or dependent variable.</p>
<p><strong>multivariate model</strong>: A model that <strong>simultaneously</strong> predicts more than one dependent variable, e.g.&nbsp;a model to predict systolic and diastolic blood pressure or a model to predict systolic blood pressure 5 min. and 60 min. after drug administration.</p>
<aside>
Taken from Frank Harrell’s <a href="http://hbiostat.org/doc/glossary.pdf">glossary</a>
</aside></section><section id="regression-model" class="level2 page-columns page-full"><h2 class="anchored" data-anchor-id="regression-model">Regression Model</h2>
<p>The choice of regression model depends on the nature of the outcome or dependent variable.</p>
<ul>
<li><p>Continuous outcome: linear regression model</p></li>
<li><p>Binary outcome: binary logistic regression model</p></li>
<li><p>Ordinal outcome: ordinal regression model</p></li>
<li><p>Time to event outcome: Cox proportional hazards model<sup>1</sup></p></li>
</ul>
<p>Regression models are used for</p>
<ul>
<li><p>hypothesis testing</p></li>
<li><p>estimation (with confounder adjustment to get adjusted estimates of effects)</p></li>
<li><p>prediction</p></li>
</ul>
<section id="notation" class="level3 page-columns page-full"><h3 class="anchored" data-anchor-id="notation">Notation</h3>
<p><img src="https://latex.codecogs.com/png.latex?E(y%7Cx)%20=%20%5Calpha%20+%20%5Cbeta%20x"> (simple regression)</p>
<p><img src="https://latex.codecogs.com/png.latex?E(y%7Cx)%20=%20%5Calpha%20+%20%5Cbeta_1x_1%20+%20%5Cbeta_2x_2"> (multiple regression)</p>
<p><img src="https://latex.codecogs.com/png.latex?y">: Response, dependent, or outcome variable</p>
<p><img src="https://latex.codecogs.com/png.latex?x">: Predictor or independent variable</p>
<p><img src="https://latex.codecogs.com/png.latex?E(y%7Cx)"> : Expected value of <img src="https://latex.codecogs.com/png.latex?y"> conditioned on the value of <img src="https://latex.codecogs.com/png.latex?x"></p>
<p><img src="https://latex.codecogs.com/png.latex?%5Cbeta">: Slope of <img src="https://latex.codecogs.com/png.latex?y"> on <img src="https://latex.codecogs.com/png.latex?x"> (<img src="https://latex.codecogs.com/png.latex?%5Cfrac%7B%5CDelta%7By%7D%7D%7B%5CDelta%7Bx%7D%7D">)</p>
<!-- $e$: random error = residual = variation in $y$ when holding $x$ constant (e.g., variation in gait speed [$y$] between patients of the same age [$x$]) -->
<aside>
June says I have maxed out my quota for equations and symbols
</aside><p>Watch this video which explains the notation of simple linear regression</p>
<aside>
Use this <a href="https://www.youtube.com/watch?v=KsVBBJRb9TE&amp;list=PLvxOuBpazmsND0vmkP1ECjTloiVz-pXla">link</a> if the video doesn’t play
</aside><iframe width="560" height="350" src="https://www.youtube.com/embed/KsVBBJRb9TE" frameborder="0" allowfullscreen="">
</iframe>
</section><section id="interpretating-x" class="level3"><h3 class="anchored" data-anchor-id="interpretating-x">Interpretating <img src="https://latex.codecogs.com/png.latex?x">
</h3>
<ul>
<li><p>Generally speaking, <img src="https://latex.codecogs.com/png.latex?x"> is the predictor or independent variable - a variable that is associated with the outcome (<img src="https://latex.codecogs.com/png.latex?y">)</p></li>
<li><p>Depending on the study design, <img src="https://latex.codecogs.com/png.latex?x"> can also represent the explanatory variable, risk factor, confounder, covariate, or covariable. With multiple <img src="https://latex.codecogs.com/png.latex?x">’s, they can be (i) multiple risk factors, (ii) treatment variable plus baseline outcomes plus patient descriptors (age, gender), or (iii) different levels of a nominal (categorical) variable (e.g., race)</p></li>
</ul></section><section id="interpretating-beta" class="level3 page-columns page-full"><h3 class="anchored" data-anchor-id="interpretating-beta">Interpretating <img src="https://latex.codecogs.com/png.latex?%5Cbeta">
</h3>
<ul>
<li><p>slope</p></li>
<li><p>regression coefficient</p></li>
<li><p>effect size of a given predictor</p></li>
<li><p>effect of increasing <img src="https://latex.codecogs.com/png.latex?x"> by one unit on the change in the mean of <img src="https://latex.codecogs.com/png.latex?y">, holding all other <img src="https://latex.codecogs.com/png.latex?x">’s constant</p></li>
<li><p>with multiple <img src="https://latex.codecogs.com/png.latex?x">’s, the <img src="https://latex.codecogs.com/png.latex?%5Cbeta">s represent the <em>partial</em> effects of <img src="https://latex.codecogs.com/png.latex?x">s</p></li>
</ul>
<p><img src="https://latex.codecogs.com/png.latex?E(y%7Cx)%20=%20%5Calpha%20+%20%5Cbeta_1x_1%20+%20%5Cbeta_2x_2%20+%20%5Cbeta_3x_3"></p>
<aside>
Note: By holding all other <img src="https://latex.codecogs.com/png.latex?x">’s (confounders) constant, we are minimizing the risk of confounding!
</aside><p><img src="https://latex.codecogs.com/png.latex?%5Cbeta_1"> interpretation: Holding <img src="https://latex.codecogs.com/png.latex?x_2"> and <img src="https://latex.codecogs.com/png.latex?x_3"> constant, how much does mean <img src="https://latex.codecogs.com/png.latex?y"> change when <img src="https://latex.codecogs.com/png.latex?x_1"> changes by 1 unit?</p>
<p><img src="https://latex.codecogs.com/png.latex?%5Cbeta_2"> interpretation: Holding <img src="https://latex.codecogs.com/png.latex?x_1"> and <img src="https://latex.codecogs.com/png.latex?x_3"> constant, how much does mean <img src="https://latex.codecogs.com/png.latex?y"> change when <img src="https://latex.codecogs.com/png.latex?x_2"> changes by 1 unit?</p>
<p><img src="https://latex.codecogs.com/png.latex?%5Cbeta_3"> interpretation: Holding <img src="https://latex.codecogs.com/png.latex?x_1"> and <img src="https://latex.codecogs.com/png.latex?x_2"> constant, how much does mean <img src="https://latex.codecogs.com/png.latex?y"> change when <img src="https://latex.codecogs.com/png.latex?x_3"> changes by 1 unit?</p>
<p>IQR-<img src="https://latex.codecogs.com/png.latex?%5Cbeta"> = change in the mean of <img src="https://latex.codecogs.com/png.latex?y"> per one <em>IQR</em> increase in <img src="https://latex.codecogs.com/png.latex?x"></p>
<p>Watch this video which explains the interpretation of <img src="https://latex.codecogs.com/png.latex?%5Cbeta"> from a simple linear regression model. Please note that <img src="https://latex.codecogs.com/png.latex?%5Cbeta_0"> in the video refers to <img src="https://latex.codecogs.com/png.latex?%5Calpha"> using our notation.</p>
<aside>
Use this <a href="https://www.youtube.com/watch?v=I8Dr1OGUdZQ&amp;list=PLvxOuBpazmsND0vmkP1ECjTloiVz-pXla&amp;index=3">link</a> if the video doesn’t play
</aside><iframe width="560" height="350" src="https://www.youtube.com/embed/I8Dr1OGUdZQ" frameborder="0" allowfullscreen="">
</iframe>
<p>Watch this <a href="https://www.youtube.com/watch?v=dQNpSa-bq4M">video</a> which explains the interpretation of <img src="https://latex.codecogs.com/png.latex?%5Cbeta"> from a multivariable linear regression model. Please note that <img src="https://latex.codecogs.com/png.latex?%5Cbeta_0"> in the video refers to <img src="https://latex.codecogs.com/png.latex?%5Calpha"> using our notation. To jump straight into <img src="https://latex.codecogs.com/png.latex?%5Cbeta"> interpretation, start from minute <img src="https://latex.codecogs.com/png.latex?14"> of the video.</p>
<p>Logistic regression = exponentiating <img src="https://latex.codecogs.com/png.latex?%5Cbeta"> = Odds Ratio</p>
<p>Cox proportional hazards regression = exponentiating <img src="https://latex.codecogs.com/png.latex?%5Cbeta"> = Hazard Ratio (HR)</p>
</section></section><section id="linear-regression" class="level2 page-columns page-full"><h2 class="anchored" data-anchor-id="linear-regression">Linear Regression</h2>
<section id="example-1" class="level3 page-columns page-full"><h3 class="anchored" data-anchor-id="example-1">Example 1</h3>
<p>Expected post-Rx disability = <img src="https://latex.codecogs.com/png.latex?24"> + <img src="https://latex.codecogs.com/png.latex?0.71%5Ctimes">baseline score + <img src="https://latex.codecogs.com/png.latex?12.7%5Ctimes">acupuncture</p>
<ul>
<li>Interpretation: <strong>12.7</strong> represents the difference between groups on mean change scores. Outcome score improved by an estimated <strong>12.7</strong> points more on average in the acupuncture group than in the placebo group.</li>
</ul>
<aside>
In a research paper, the authors will report the <img src="https://latex.codecogs.com/png.latex?%5Cbeta"> for the <code>acupuncture</code> (<em>12.7</em>) term
</aside><ul>
<li>An analysis of covariance (ANCOVA) adjusts each patient’s follow up score for his or her baseline score<span class="citation" data-cites="vickers2001ancova">(Vickers and Altman 2001)</span>
</li>
</ul>
<div class="cell page-columns page-full" data-layout-align="center">
<div class="cell-output-display page-columns page-full">
<div class="quarto-figure quarto-figure-center page-columns page-full">
<figure class="figure page-columns page-full"><p><img src="https://.com/ebp/regression/images/ancova.png" class="img-fluid figure-img" style="width:100.0%"></p>
<p></p><figcaption class="figure-caption margin-caption">The estimated difference between the groups from analysis of covariance is the vertical distance between the red and dotted lines. This figure is taken from Vickers et al <span class="citation" data-cites="vickers2001ancova">(Vickers and Altman 2001)</span></figcaption><p></p>
</figure>
</div>
</div>
</div>
<aside>
Disclaimer: Don’t freak out if you don’t understand this. As mentioned, the most important result is <em>12.7</em> - the <img src="https://latex.codecogs.com/png.latex?%5Cbeta"> for acupuncture
</aside><ul>
<li>
<strong>ANCOVA</strong>: Analysis of covariance is <em>just</em> multiple regression (i.e., a linear model ) where one variable is of major interest and is categorical (e.g., treatment group). In classic ANCOVA there is a treatment variable and a continuous covariate used to reduce unexplained variation in the dependent variable, thereby increasing power.</li>
</ul>
<aside>
Taken from Frank Harrell’s <a href="http://hbiostat.org/doc/glossary.pdf">glossary</a>
</aside></section><section id="example-2" class="level3 page-columns page-full"><h3 class="anchored" data-anchor-id="example-2">Example 2</h3>
<p>Table 2, taken from our JoSPT paper<span class="citation" data-cites="pua2017associations">(Pua et al. 2017)</span>, describes how to interpret the output from a linear and (ordinal) logistic regression model.</p>
<div class="l-body">
<table class="table">
<colgroup>
<col style="width: 10%">
<col style="width: 89%">
</colgroup>
<thead><tr class="header">
<th>Number</th>
<th>Question</th>
</tr></thead>
<tbody>
<tr class="odd">
<td>1</td>
<td>What is the study aim?</td>
</tr>
<tr class="even">
<td>2</td>
<td>What are the predictor(s)-of-interest and outcomes?</td>
</tr>
<tr class="odd">
<td>3</td>
<td>What are the confounders - and why?</td>
</tr>
<tr class="even">
<td>4</td>
<td>Why did the authors use both linear and ordinal regression analyses?</td>
</tr>
</tbody>
</table>
</div>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure"><p><img src="https://.com/ebp/regression/images/jospt_rfd_table.png" class="img-fluid figure-img" width="1100"></p>
</figure>
</div>
</div>
</div>
<aside>
Paper can be found in <code>Articles</code> section.
</aside></section><section id="example-32" class="level3 page-columns page-full"><h3 class="anchored" data-anchor-id="example-32">Example 3<sup>2</sup>
</h3>
<p>Independent <em>t</em>-test is a special cases of simple linear regression</p>
<p><img src="https://latex.codecogs.com/png.latex?E(y%7Cx)%20=%20%5Calpha%20+%20%5Cbeta%20x"></p>
<p><img src="https://latex.codecogs.com/png.latex?x">: Single binary predictor</p>
<p><img src="https://latex.codecogs.com/png.latex?%5Cbeta">: the slope of a binary predictor (<img src="https://latex.codecogs.com/png.latex?x">) is equivalent to the difference in mean <img src="https://latex.codecogs.com/png.latex?y"> between 2 groups</p>
<p>When you replace the binary predictor (<img src="https://latex.codecogs.com/png.latex?x">) by a multi-group/categorical predictor, linear regression and multi-group ANOVA are identical. Hence, multi-group ANOVA is a special case of linear regression</p>
<aside>
Because regression analysis generalizes many special tests (e.g., t-test, ANOVA, Wilcoxon Mann Whitney U test, Kruskal-Wallis test), this explains our focus on regression analysis
</aside></section></section><section id="lrm" class="level2 page-columns page-full"><h2 class="anchored" data-anchor-id="lrm">Logistic Regression</h2>
<section id="the-challenge" class="level3"><h3 class="anchored" data-anchor-id="the-challenge">The Challenge</h3>
<ul>
<li><p>Logistic regression is a regression technique that is used to analyse binary outcome.</p></li>
<li><p>Our response/outcome variable takes on 2 values, 0 or 1, and we convert them into the probability of a “one” response, given a set of predictors.</p></li>
<li><p>We cannot use linear regression to predict probabilities because it may predict probabilities &gt;1 or &lt;0</p></li>
</ul></section><section id="the-workaround" class="level3 page-columns page-full"><h3 class="anchored" data-anchor-id="the-workaround">The Workaround</h3>

<div class="no-row-height column-margin column-container"><div class="">
<p>For the curious who wants to know why the exponentiated <img src="https://latex.codecogs.com/png.latex?%5Cbeta"> is an OR. But don’t freak out if you don’t understand this!</p>
</div></div><p><img src="https://latex.codecogs.com/png.latex?%0A%5Cbegin%7Bsplit%7D%0A%5Ctext%7BProbabilty%20=%20%7D%5Cpi%20%5Cin%20%5B0,1%5D%20%5C%5C%0A%5Ctext%7BOdds%20=%20%7D%20%5Cfrac%7B%5Ctext%7Bprob%7D%7D%7B1%20-%20%5Ctext%7Bprob%7D%7D%20=%20%5Cfrac%20%7B%5Cpi%7D%7B(1-%5Cpi)%7D%20%5Cin%20%5B0,%20+%5Cinfty)%20%5C%5C%0A%5Ctext%7Blog%20(odds)%20=%20%7D%20%20%5Ctext%7Blog%7D%5Cleft(%5Cfrac%7B%5Ctext%7Bprob%7D%7D%7B1%20-%20%5Ctext%7Bprob%7D%7D%5Cright)%20=%20%5Ctext%7Blog%7D%5Cleft(%5Cfrac%20%7B%5Cpi%7D%7B(1-%5Cpi)%7D%5Cright)%20%5Cin%20%5B-%5Cinfty,%20+%5Cinfty)%20%5C%5C%0A%5Clog(%5Ctext%7Bodds%7D)%20=%20%5Clog%5Cleft(%5Cfrac%7B%5Cpi%7D%7B1-%5Cpi%7D%5Cright)%20=%20%5Cbeta_0%20+%20%5Cbeta_1%20X_1%20+%20%5Ccdots%20+%20%5Cbeta_p%20X_p%20%5C%5C%0A%5Cbeta_1%20=%20%5Clog(%5Ctext%7Bodds%7D_%7Bx+1%7D)%20-%20%5Clog(%5Ctext%7Bodds%7D_x)%20%5C%5C%0Ae%5E%7B%5Cbeta_1%7D%20=%20%5Cfrac%7B%5Ctext%7Bodds%7D_%7Bx+1%7D%7D%7B%5Ctext%7Bodds%7D_x%7D%20=%20%5Ctext%7Bodds%20ratio%20%5BOR%5D%7D%0A%5Cend%7Bsplit%7D%0A"></p>



</section></section><div id="quarto-appendix" class="default"><section class="quarto-appendix-contents"><h2 class="anchored quarto-appendix-heading">References</h2><div id="refs" class="references csl-bib-body hanging-indent">
<div id="ref-pua2017associations" class="csl-entry">
Pua, Yong-Hao, Benjamin F Mentiplay, Ross A Clark, and Jia-Ying Ho. 2017. <span>“Associations Among Quadriceps Strength and Rate of Torque Development 6 Weeks Post Anterior Cruciate Ligament Reconstruction and Future Hop and Vertical Jump Performance: A Prospective Cohort Study.”</span> <em>The Journal of Orthopaedic &amp; Sports Physical Therapy</em> 47 (11): 845–52. <a href="https://doi.org/10.2519/jospt.2017.7133">https://doi.org/10.2519/jospt.2017.7133</a>.
</div>
<div id="ref-vickers2001ancova" class="csl-entry">
Vickers, Andrew J, and Douglas G Altman. 2001. <span>“Analysing Controlled Trials with Baseline and Follow up Measurements.”</span> <em>BMJ</em> 323 (7321): 1123–24.
</div>
</div></section><section id="footnotes" class="footnotes footnotes-end-of-document"><h2 class="anchored quarto-appendix-heading">Footnotes</h2>
<ol>
<li id="fn1"><p>Not covered in this workshop↩︎</p></li>
<li id="fn2"><p>Bonus Example. Don’t freak out if you don’t understand this↩︎</p></li>
</ol></section></div> ]]></description>
  <category>regression</category>
  <category>odds ratio</category>
  <category>beta</category>
  <guid>https://.com/ebp/regression/regression.html</guid>
  <pubDate>Wed, 15 Jul 2020 16:00:00 GMT</pubDate>
  <media:content url="https://.com/ebp/regression/images/ancova.png" medium="image" type="image/png" height="116" width="144"/>
</item>
<item>
  <title>Confounding</title>
  <dc:creator>SGH PT Dept</dc:creator>
  <link>https://.com/ebp/confounding/confounding.html</link>
  <description><![CDATA[ <!-- # Confounding --><!-- ## Question: Good or Bad? --><!-- >> RCTs often do not mimic clinical practice because patients enrolled in an RCT can be quite different from patients in clinical practice --><!-- - This may be **necessary** as it allows an RCT to control for **confounding** when estimating the **true** treatment effects --><!-- - Another goal of an RCT is to estimate [relative](http://www.fharrell.com/post/rct-mimic/) treatment effects --><section id="definition" class="level2 page-columns page-full"><h2 class="anchored" data-anchor-id="definition">Definition</h2>
<ul>
<li><p>Confounding is the bias or systematic error in the estimation of true treatment (predictor) effects</p></li>
<li><p>Confounding is caused by a variable (“confounder”) that is related to <em>both</em> predictor and outcome. However, a confounder is <em>not</em> caused by the predictor</p></li>
</ul>
<div class="cell">

</div>
<section id="comprehensive-overview-provided-by-z-statistics" class="level3 page-columns page-full"><h3 class="anchored" data-anchor-id="comprehensive-overview-provided-by-z-statistics">Comprehensive overview provided by <a href="http://www.zstatistics.com/">Z Statistics</a>
</h3>
<iframe width="560" height="315" src="https://www.youtube.com/embed/SjIbrNYAd5Y" frameborder="0" allowfullscreen="">
</iframe>
<aside>
Use this <a href="https://www.youtube.com/watch?v=SjIbrNYAd5Y">link</a> if the video doesn’t play
</aside></section><section id="example-1-smoking-chd-association-confounded-by-age" class="level3 page-columns page-full"><h3 class="anchored" data-anchor-id="example-1-smoking-chd-association-confounded-by-age">Example 1: Smoking-CHD Association confounded by Age</h3>
<aside>
Use this <a href="https://www.youtube.com/watch?v=WU6zCCYbGHU">link</a> if the video doesn’t play
</aside><iframe width="560" height="315" src="https://www.youtube.com/embed/WU6zCCYbGHU" frameborder="0" allowfullscreen="">
</iframe>
<aside>
If you have understood the concepts of confounding, please give credit to this speaker - not me!
</aside></section><section id="example-2-confounding-by-disease-severity" class="level3"><h3 class="anchored" data-anchor-id="example-2-confounding-by-disease-severity">Example 2: Confounding by disease severity</h3>
<ul>
<li><p>Patients with greater disease severity (the confounder) are likely to receive more intensive therapy</p></li>
<li><p>Patients with greater disease severity are likely to have poor clinical outcomes</p></li>
<li><p>Thus, we may observe that intensive therapy is associated with poorer clinical outcomes. In other words, disease severity has distorted or confounded the estimation of the true therapy effects</p></li>
</ul></section><section id="example-3-confounding-by-treatment-indication" class="level3"><h3 class="anchored" data-anchor-id="example-3-confounding-by-treatment-indication">Example 3: Confounding by treatment indication</h3>
<ul>
<li><p>Confounding caused by variables related to both treatment decision and outcomes</p></li>
<li><p>In clinical practice, a therapist gives Patient A Treatment A and Patient B Treatment B</p></li>
<li><p>We may be tempted to compare Treatment A and Treatment B by comparing the outcomes of Patient A and Patient B. Unfortunately, this comparison of treatment effects is prone to confounding (by indication)</p></li>
<li><p>Potential dangers of ignoring confounding by severity/treatment indication are highlighted <a href="https://www.jamda.com/article/S1525-8610(19)30370-6/fulltext">here</a></p></li>
</ul></section></section><section id="controlling-for-confounding" class="level2 page-columns page-full"><h2 class="anchored" data-anchor-id="controlling-for-confounding">Controlling for confounding</h2>
<ul>
<li>This involves breaking or removing the connection between treatment group variable and the confounder</li>
</ul>
<div class="cell">
<div class="cell-output-display">
<p><img src="https://.com/ebp/confounding/images/confound_break.png" class="img-fluid" width="424"></p>
</div>
</div>
<section id="study-design-method-randomization" class="level3 page-columns page-full"><h3 class="anchored" data-anchor-id="study-design-method-randomization">Study Design Method: Randomization</h3>
<ul>
<li><p>Large randomized trials ensure that treatment and control groups are balanced with respect to factors associated with outcomes (eg., age, sex, disease severity, and comorbidity) and they thus provide the optimal approach to address questions about treatment effects</p></li>
<li><p>In an RCT, an intention to treat analysis (ITT) is a method/strategy of data analysis that compares patients in the groups to which they are originally randomly allocated.</p></li>
<li><p>ITT ensures that the treatment groups remain similar in baseline characteristics; hence, ITT minimizes confounding</p></li>
<li><p>RCTs often do not mimic clinical practice because patients enrolled in an RCT can be quite different from patients in clinical practice. This may be <strong>necessary</strong> as it allows an RCT to control for <strong>confounding</strong> when estimating the <strong>true</strong> treatment effects.</p></li>
</ul>
<div class="cell page-columns page-full" data-layout-align="center">
<div class="cell-output-display page-columns page-full">
<div class="quarto-figure quarto-figure-center page-columns page-full">
<figure class="figure page-columns page-full"><p><img src="https://.com/ebp/confounding/images/confoundrct.png" class="img-fluid figure-img" style="width:85.0%"></p>
<p></p><figcaption class="figure-caption margin-caption">RCT controls confounding. Figure taken from Agoritsas et al <span class="citation" data-cites="agoritsas2017">(Agoritsas et al. 2017)</span></figcaption><p></p>
</figure>
</div>
</div>
</div>
</section><section id="statistical-method-regression" class="level3 page-columns page-full"><h3 class="anchored" data-anchor-id="statistical-method-regression">Statistical Method: Regression</h3>
<ul>
<li><p>Regression methods condition on confounders when estimating the “true” treatment effects</p></li>
<li><p>Conceptually, we are averaging the treatment effects across the levels/strata of the confounder</p></li>
<li><p>Conditioning = Holding values (of the confounder) constant. Because the confounder is held constant at each stratum, regression analyses <strong>attempt</strong> to “level the playing field” for treatment groups</p></li>
<li><p>Conditioning can be done using stratification analyses or multivariable regression analyses</p></li>
<li><p><strong>We adjusted or controlled for age…</strong>: Assessing the effect of one variable while accounting for the effect of another (confounding) variable. In a non-randomized study comparing the effects of treatments A and B on blood pressure reduction, the patients’ ages may have been used to select the treatment. It would be advisable in that case to control for the effect of age before estimating the treatment effect. This can be done using a regression model with blood pressure as the dependent variable and treatment and age as the independent variables (controlling for age using subtraction) or crudely and approximately (with some residual confounding) by stratifying by deciles of age and averaging the treatment effects estimated within the deciles. Adjustment results in adjusted odds ratios, adjusted hazard ratios, adjusted slopes, etc.</p></li>
</ul>
<aside>
Taken from Frank Harrell’s <a href="http://hbiostat.org/doc/glossary.pdf">glossary</a>
</aside><div class="cell page-columns page-full" data-layout-align="center">
<div class="cell-output-display page-columns page-full">
<div class="quarto-figure quarto-figure-center page-columns page-full">
<figure class="figure page-columns page-full"><p><img src="https://.com/ebp/confounding/images/stratify.png" class="img-fluid figure-img" style="width:100.0%"></p>
<p></p><figcaption class="figure-caption margin-caption">Statistical adjustment for Age. Figure taken from Agoritsas et al <span class="citation" data-cites="agoritsas2017">(Agoritsas et al. 2017)</span></figcaption><p></p>
</figure>
</div>
</div>
</div>
<aside>
Disclaimer: Don’t freak out if you don’t understand this. It is nice but not necessary to understand this
</aside></section><section id="comparison" class="level3 page-columns page-full"><h3 class="anchored" data-anchor-id="comparison">Comparison</h3>
<ul>
<li><p>Large randomized trials ensure that treatment and control groups are balanced with respect to (known and unknown) factors associated with outcomes (typically age, sex, disease severity, and comorbidity — “prognostic factors”) and thus provide the optimal approach to address questions about the benefits and harms of interventions.</p></li>
<li><p>Observational treatment comparisons = No treatment group randomization = More “real world” (reflective of clinical practice) = Greater risk of (known and <strong>unknown</strong>) confounding when estimating therapy effects</p></li>
<li><p>In observational treatment comparisons, we could use regression methods to adjust for <strong>known</strong> confounding. Hence, we are constantly haunted by the possibility that residual confounding may creep into our results. Residual confounding is the bias that remains even after statistical adjustment and it is caused by imperfectly measured confounders and unknown confounders.</p></li>
</ul>
<div class="cell page-columns page-full" data-layout-align="center">
<div class="cell-output-display page-columns page-full">
<div class="quarto-figure quarto-figure-center page-columns page-full">
<figure class="figure page-columns page-full"><p><img src="https://.com/ebp/confounding/images/confoundobs.png" class="img-fluid figure-img" style="width:85.0%"></p>
<p></p><figcaption class="figure-caption margin-caption">Confounding in observational study. Figure taken from Agoritsas et al <span class="citation" data-cites="agoritsas2017">(Agoritsas et al. 2017)</span></figcaption><p></p>
</figure>
</div>
</div>
</div>
<aside>
Disclaimer: Don’t freak out if you don’t understand this. It is nice but not necessary to understand this
</aside></section></section><section id="short-quiz" class="level2 page-columns page-full"><h2 class="anchored" data-anchor-id="short-quiz">Short Quiz</h2>
<aside>
Quiz questions from Christina Saunders (I could not locate the link where she has posted these questions)
</aside><p>Question 1: Is the drug beneficial?</p>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure"><p><img src="https://.com/ebp/confounding/images/quiz1.png" class="img-fluid figure-img" style="width:100.0%"></p>
</figure>
</div>
</div>
</div>
<p>Question 2: Is the drug beneficial?</p>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure"><p><img src="https://.com/ebp/confounding/images/quiz2.png" class="img-fluid figure-img" style="width:100.0%"></p>
</figure>
</div>
</div>
</div>



</section><div id="quarto-appendix" class="default"><section class="quarto-appendix-contents"><h2 class="anchored quarto-appendix-heading">References</h2><div id="refs" class="references csl-bib-body hanging-indent">
<div id="ref-agoritsas2017" class="csl-entry">
Agoritsas, Thomas, Arnaud Merglen, Nilay D Shah, Martin O’Donnell, and Gordon H Guyatt. 2017. <span>“Adjusted Analyses in Studies Addressing Therapy and Harm: Users’ Guides to the Medical Literature.”</span> <em>JAMA</em> 317 (7): 748–59.
</div>
</div></section></div> ]]></description>
  <category>confounder</category>
  <category>regression</category>
  <guid>https://.com/ebp/confounding/confounding.html</guid>
  <pubDate>Tue, 14 Jul 2020 16:00:00 GMT</pubDate>
  <media:content url="https://.com/ebp/confounding/images/confound1.png" medium="image" type="image/png" height="86" width="144"/>
</item>
<item>
  <title>General Overview</title>
  <dc:creator>SGH PT Dept</dc:creator>
  <link>https://.com/ebp/overview/overview.html</link>
  <description><![CDATA[ <div class="cell">

</div>
<section id="types-of-measurement" class="level2"><h2 class="anchored" data-anchor-id="types-of-measurement">Types of Measurement</h2>
<p>Binary: Two-level variables, e.g., yes/no, present/absent, gender</p>
<p>Nominal: Non-ordered categorical variables, e.g., race, profession</p>
<p>Ordinal: Ordered categorical variables, e.g., pain severity, radiographical osteoarthritis (OA) severity ratings (no/mild/moderate/severe OA)</p>
<p>Count: Discrete variable with integer values, e.g., Length of Stay, number of falls</p>
<p>Continuous: Numerical variable which takes a whole range of values, e.g., age, height, BMI</p>
</section><section id="mean-sd" class="level2 page-columns page-full"><h2 class="anchored" data-anchor-id="mean-sd">Mean &amp; SD</h2>
<p>Mean: Arithmetic average</p>
<p>SD: Measure of spread</p>
<ul>
<li><p>Mathematically, <img src="https://latex.codecogs.com/png.latex?%5Csurd"> of averaged squared difference of an observation from the mean</p></li>
<li><p>Can be used to estimate the dispersion of a normally distributed <em>population</em></p></li>
<li><p>An estimate of the variability of the population from which the sample was drawn <span class="citation" data-cites="altman2005statistics">(Altman and Bland 2005)</span></p></li>
<li><p>About 95% of observations of any distribution usually fall within the 2 standard deviation limits</p></li>
</ul>
<p>Asymmetric data: SD<img src="https://latex.codecogs.com/png.latex?%5Ctimes"> 2 &gt; Mean</p>
<aside>
Use this rule-of-thumb when you don’t have access to the raw data <span class="citation" data-cites="altman1996detecting">(Altman and Bland 1996)</span>
</aside><p>SE: Standard error is the SD of the sampling distribution of a statistic.</p>
<ul>
<li>SE is used to infer about the range of plausible values for the <em>true</em> (population) statistic.</li>
</ul></section><section id="median-iqr" class="level2 page-columns page-full"><h2 class="anchored" data-anchor-id="median-iqr">Median &amp; IQR</h2>
<p>Median: Middle sorted value</p>
<ul>
<li>Value such that around <img src="https://latex.codecogs.com/png.latex?%5Cfrac%7B1%7D%7B2%7D"> of the values are below it and above it</li>
</ul>
<aside>
This holds for truly continuous data
</aside><ul>
<li><p>May not divide sample into <img src="https://latex.codecogs.com/png.latex?%5Cfrac%7B1%7D%7B2%7D"> for “clumped” data</p></li>
<li><p>Mean is better than the median when the distribution (i) contains heavy ties, (ii) is limited or well-behaved</p></li>
</ul>
<p>IQR: Measure of spread</p>
<ul>
<li><p>Defined by Quartile<img src="https://latex.codecogs.com/png.latex?_%7B1%7D"> (<img src="https://latex.codecogs.com/png.latex?Q_1">) and Quartile<img src="https://latex.codecogs.com/png.latex?_%7B3%7D"> (<img src="https://latex.codecogs.com/png.latex?Q_3">)</p></li>
<li><p>Interval containing the middle <img src="https://latex.codecogs.com/png.latex?%5Cfrac%7B1%7D%7B2%7D"> of the sample</p></li>
</ul></section><section id="p-value" class="level2 page-columns page-full"><h2 class="anchored" data-anchor-id="p-value">
<em>P</em>-value</h2>
<ul>
<li><p><em>P</em>-value = Probability value</p></li>
<li><p>Assuming that <em>H</em><img src="https://latex.codecogs.com/png.latex?_%7B0%7D"> were true, what is the probability of obtaining a result (statistic) as or more extreme than our observed result?</p></li>
<li><p>If the probability is low (often set at <em>P</em>&lt;0.05), we have sufficient evidence to reject <em>H</em><img src="https://latex.codecogs.com/png.latex?_%7B0%7D"> and accept <em>H</em><img src="https://latex.codecogs.com/png.latex?_%7B1%7D"></p></li>
<li><p>If the probability is low, we fail to reject <em>H</em><img src="https://latex.codecogs.com/png.latex?_%7B0%7D"> but we do not speak of accepting <em>H</em><img src="https://latex.codecogs.com/png.latex?_%7B0%7D">. The <em>P</em>-value provides evidence against a <em>null</em> hypothesis, <strong>never</strong> evidence for something.</p></li>
<li><p>The <em>P</em>-value is influenced by sample size and effect size. Classical statistical testing does not consider clinical significance: Clinical relevance cannot be concluded from small <em>P</em>-values.</p></li>
</ul>
<aside>
Use this <a href="https://www.youtube.com/embed/vemZtEM63GY">link</a> if the video doesn’t play
</aside><iframe width="560" height="315" src="https://www.youtube.com/embed/vemZtEM63GY" frameborder="0" allowfullscreen="">
</iframe>
<aside>
If you have understood the concept of P-values, please give credit to Josh Starmer - not me!
</aside></section><section id="confidence-interval" class="level2 page-columns page-full"><h2 class="anchored" data-anchor-id="confidence-interval">Confidence Interval</h2>
<ul>
<li>Range of values within which that the “true” (population) summary statistic (e.g., mean, correlation coefficient, or difference score) would plausibly lie.</li>
</ul>
<p>To interpret a 95% confidence interval,</p>
<ul>
<li><p>The wrong way: There is a 95% chance that the unknown true value lies within the interval</p></li>
<li><p>The rough way: We are 95% confident that the unknown true value lies within the interval</p></li>
<li><p>The exact way: If we were to repeat experiment many times and to compute, in each experiment, a confidence interval for the summary statistic, 95% of these CIs would contain the true (population) value. Or, this confidence interval is computed by an algorithm that has a 95% probability of including the true value in repeated sampling.</p></li>
</ul>
<aside>
Use this <a href="https://www.youtube.com/embed/TqOeMYtOc1w">link</a> if the video doesn’t play
</aside><iframe width="560" height="315" src="https://www.youtube.com/embed/TqOeMYtOc1w" frameborder="0" allowfullscreen="">
</iframe>
<aside>
If you have understood the concept of confidence interval, please give credit to <a href="https://www.youtube.com/channel/UCtYLUTtgS3k1Fg4y5tAhLbw">Josh Starmer</a> - not me!
</aside></section><section id="interpreting-p-values-and-95ci." class="level2 page-columns page-full"><h2 class="anchored" data-anchor-id="interpreting-p-values-and-95ci.">Interpreting <em>P</em>-values and 95%CI.</h2>
<style>
div.blue { background-color:#e6f0ff; border-radius: 0px; padding: 0px;}
</style>
<div class="blue">
<p>In general, the only way that a large P -value can be interpreted is for example “The study did not provide sufficient evidence for an effect.” One cannot say “Because <em>P</em> = 0.70, we conclude the drug has no effect”. Only when the corresponding confidence interval excludes both clinically significant benefit and harm can one make such a conclusion. A large <em>P</em>-value by itself merely means that a higher sample size is required to allow conclusions to be drawn</p>
</div>
<aside>
Go to Frank Harrell’s <a href="https://discourse.datamethods.org/t/author-checklist/3407">DataMethods</a> for more details
</aside><p><br></p>
<iframe width="560" height="315" src="https://www.youtube.com/embed/PPD8lER8ju4" frameborder="0" allowfullscreen="">
</iframe>
<aside>
Adriene Hill from <a href="https://thecrashcourse.com/courses/statistics">Crash Course</a> explains how to interpret “large” P-values
</aside></section><section id="p-value-point-estimate-95-ci" class="level2 page-columns page-full"><h2 class="anchored" data-anchor-id="p-value-point-estimate-95-ci">
<em>P-value</em>, Point Estimate, 95% CI</h2>
<p>The <em>P</em>-value<br>
This quantifies the evidence for a non-zero between-group difference. A large <em>P</em>-value, by itself, only suggests that we have insufficient evidence for a between-group difference.</p>
<aside>
Remember: absence of evidence may not represent evidence of absence.
</aside><p>The observed mean difference<br>
Appraise this estimate against the MCID value.<br><em>What we do know</em>: An individual-level MCID is almost always <a href="https://rapm.bmj.com/content/early/2022/03/31/rapm-2021-103331"><strong>greater</strong> than a group-level MCID</a><br><em>What we do not know</em>: how much greater is <strong>greater</strong>?</p>
<aside>
In the absence of data, Yonghao suggests 0.5*individual-level MCID. But how much we can trust this estimate?
</aside><p>The 95% CI<br>
(Very) Loosely speaking, this represents the range of plausible values for the true between-group differences.<br>
Wide CI: there is great uncertainty about the true between-group differences<br>
Narrow CI: there is little uncertainty about the true between-group differences. When there is little uncertainty, the finding is almost always clinically relevant.</p>
<aside>
Hence, it is possible to have a finding that is statistically non-significant but highly clinically relevant.
</aside><p>Example<br>
Findings<br>
We observed a between-group difference of 6 points on the ODI, with a corresponding <em>P</em>-value of 0.01 and a 95%CI of 1 to 12 points</p>
<p>Appraisal<br>
The <em>P</em>-value: We have evidence of a non-zero between-group difference<br>
The Point estimate: If we are willing to assume a group-level MCID of 6 points, the observed between-group difference is probably clinically meaningful<br>
The 95% CI: The wide 95%CI includes clinically trivial values; hence, there is uncertainty about the true between-group difference</p>
<aside>
We need to consider whether the 95%CI includes/excludes clinically trivial results.
</aside><p>Inference<br>
Whilst we have evidence that two groups are different on the ODI and the observed between-group difference appeared to be clinically meaningful, there is still uncertainty about the true between-group differences.</p>
<div class="l-body">
<table class="table">
<colgroup>
<col style="width: 32%">
<col style="width: 67%">
</colgroup>
<thead><tr class="header">
<th>Findings</th>
<th>Interpretation</th>
</tr></thead>
<tbody>
<tr class="odd">
<td>P&lt;0.05</td>
<td>Evidence of a (non-zero) treatment difference/effect</td>
</tr>
<tr class="even">
<td>P&gt;0.05</td>
<td>Insufficient/No evidence of association (≠ evidence of no treatment difference)<sup>1</sup>
</td>
</tr>
<tr class="odd">
<td>(1) P&lt;0.05; 95% CIs exclude trivial effects</td>
<td>Evidence of a clinically meaningful treatment difference</td>
</tr>
<tr class="even">
<td>(2) P&lt;0.05; 95% CIs exclude meaningful effects</td>
<td>Evidence of a treatment diff; however, this difference is not clinically meaningful</td>
</tr>
<tr class="odd">
<td>(3) P&lt;0.05; 95% CIs include trivial + meaningful effects</td>
<td>Cannot exclude non-clinically meaningful treatment difference</td>
</tr>
<tr class="even">
<td>(4) P&gt;0.05; 95% CIs exclude meaningful effects</td>
<td>(Possibly) Evidence of no treatment difference</td>
</tr>
<tr class="odd">
<td>(5) P&gt;0.05; 95% CI limits include meaningful effects</td>
<td>CI indicates a wide range of plausible true treatment differences (inconclusive finding as all scenarios are possible)</td>
</tr>
<tr class="even">
<td>(6) P&gt;0.05; 95% CI limits include trivial + meaningful effects</td>
<td>No evidence of treatment difference, however, we cannot exclude clinically important difference</td>
</tr>
</tbody>
</table>
</div>
</section><section id="bayesian-statistics" class="level2 page-columns page-full"><h2 class="anchored" data-anchor-id="bayesian-statistics">Bayesian Statistics</h2>
<ul>
<li><p>A branch of statistics that (i) uses Bayes Theorem and (ii) doesn’t use P-values and generally does not test hypotheses.</p></li>
<li><p>Bayesian Statistics requires one to formally specify a probability distribution encapsulating the prior knowledge about, say, a treatment effect.</p></li>
</ul>
<aside>
This section is taken from Frank Harrell’s <a href="http://hbiostat.org/glossary/">glossary</a>
</aside><ul>
<li>The state of prior knowledge can be specified as <img src="https://latex.codecogs.com/png.latex?no"> knowledge” by using a flat distribution, although this can lead to wild and nonsensical estimates.</li>
<li>Once the prior distribution is specified, the data are used to modify the prior state of knowledge to obtain the post-experiment state of knowledge.</li>
<li>Final probabilities computed in the Bayesian framework are probabilities of various treatment effects.</li>
</ul>
<section id="comparing-the-2-schools-of-thought" class="level3"><h3 class="anchored" data-anchor-id="comparing-the-2-schools-of-thought">Comparing the 2 schools of thought</h3>
<div class="l-body">
<table class="table">
<colgroup>
<col style="width: 42%">
<col style="width: 57%">
</colgroup>
<thead><tr class="header">
<th>Bayesian</th>
<th>Frequentist</th>
</tr></thead>
<tbody>
<tr class="odd">
<td>Bayesian statistics aims to uncover the unknown treatment effect by providing evidence for all its possible values</td>
<td>Frequentist statistics aims to uncover the unknown treatment effect by providing evidence that it is not the null value</td>
</tr>
<tr class="even">
<td>In Bayesian statistics, one specifies the prior distribution for the unknown treatment effect and uses a data generation process to estimate the conditional data likelihood. For a given (single) data-set, Bayesian statistics provides probabilities for all possible values of the treatment effect</td>
<td>In Frequentist statistics, one specifies a null hypothesis/value about the unknown treatment effect and uses a data generation process to make infinite replications of the data. For a given null hypothesis, Frequentist statistics provides probabilities of getting studies/datasets with more extreme results than the ones that we observe. In other words, conditional on there being no treatment efficacy and no harm, the P-value is the proportion of studies with results more extreme than the ones we have</td>
</tr>
</tbody>
</table>
</div>
<style>
div.blue { background-color:#e6f0ff; border-radius: 0px; padding: 0px;}
</style>
<div class="blue">
<p>Prof Frank Harrell has provided a more detailed side-by-side <a href="https://hbiostat.org/proj/covid19/statdesign.html#bftable">comparison</a></p>
</div>
</section><section id="bayes-theorem" class="level3 page-columns page-full"><h3 class="anchored" data-anchor-id="bayes-theorem">Bayes Theorem</h3>
<p>In my opinion, <a href="https://www.3blue1brown.com/">3Blue1Brown</a> explains this the best</p>
<p><br><br><iframe width="560" height="315" src="https://www.youtube.com/embed/HZGCoVF3YvM" frameborder="0" allowfullscreen=""> </iframe></p>
<p><br><br><iframe width="560" height="315" src="https://www.youtube.com/embed/lG4VkPoG3ko" frameborder="0" allowfullscreen=""> </iframe></p>
<aside>
Go to <a href="https://betterexplained.com/articles/an-intuitive-and-short-explanation-of-bayes-theorem/">Better Explained</a> for more details
</aside></section><section id="consideration" class="level3"><h3 class="anchored" data-anchor-id="consideration">Consideration</h3>
<ul>
<li><p>Bayesian methods provide direct, simply-stated probabilities of various treatment effects.</p></li>
<li><p>The price of being able to compute probabilities of various treatment effects is the necessity of specifying a prior distribution to anchor the calculations.</p></li>
<li>
<p>Tutorials for healthcare professionals</p>
<ul>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/28081861/">Baldwin and Larson 2017</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/34040821/">Heino et al 2018</a></li>
<li>Frank Harrell’s incredibly useful <a href="https://hbiostat.org/bayes/">hbiostat pages</a>
</li>
</ul>
</li>
</ul></section></section><div id="quarto-appendix" class="default"><section id="to-note" class="level2 appendix"><h2 class="quarto-appendix-heading">To Note</h2><div class="quarto-appendix-contents">
<p>A comprehensive glossary of terms can be found <a href="http://hbiostat.org/glossary/">here</a></p>
<p>Statistical problems to avoid when reading an article can be found <a href="https://discourse.datamethods.org/t/author-checklist/3407">here</a></p>



</div></section><section class="quarto-appendix-contents"><h2 class="anchored quarto-appendix-heading">References</h2><div id="refs" class="references csl-bib-body hanging-indent">
<div id="ref-altman1996detecting" class="csl-entry">
Altman, Douglas G, and J Martin Bland. 1996. <span>“Detecting Skewness from Summary Information.”</span> <em>BMJ: British Medical Journal</em> 313 (7066): 1200.
</div>
<div id="ref-altman2005statistics" class="csl-entry">
———. 2005. <span>“Statistics Notes: Standard Deviations and Standard Errors.”</span> <em>BMJ: British Medical Journal</em> 331 (7521): 903.
</div>
</div></section><section id="footnotes" class="footnotes footnotes-end-of-document"><h2 class="anchored quarto-appendix-heading">Footnotes</h2>
<ol>
<li id="fn1"><p>Beware of making the “Absence of Evidence is NOT Evidence of Absence” fallacy↩︎</p></li>
</ol></section></div> ]]></description>
  <category>p-values</category>
  <category>confidence interval</category>
  <category>measurement type</category>
  <category>Bayesian inference</category>
  <guid>https://.com/ebp/overview/overview.html</guid>
  <pubDate>Mon, 13 Jul 2020 16:00:00 GMT</pubDate>
  <media:content url="https://.com/ebp/overview/pval.jpg" medium="image" type="image/jpeg"/>
</item>
</channel>
</rss>
